内源性皮质醇增多症对人类骨mRNA和microRNA表达的影响
该研究比较16例库欣病(CD)患者与10例临床无功能垂体腺瘤(NFPA)患者蝶骨样本的mRNA和microRNA表达,发现皮质醇增多下调成骨细胞功能与成熟相关基因、上调Wnt信号拮抗剂(Dkk1、SOST)并改变多种抑制成骨细胞生成的miR水平(p<0.05,q<0.1),长期皮质醇增多症中可见代偿性改变但均未能阻止骨形成受抑。
要点
- 库欣病患者骨样本中成骨细胞功能与成熟相关基因(ACP5、ALPL、BGLAP、COL1A1、COL1A2、BMP2、RUNX2、TWIST1)表达下调。
- 皮质醇过多上调Wnt信号拮抗剂Dkk1和SOST,并改变抑制成骨细胞生成的miR水平(p<0.05,q<0.1)。
- 长期皮质醇增多症可见Wnt10b、LRP5、LRP6上调及SFRP4下调等代偿改变,但未阻止骨形成受抑。
核心结论
- 人体内源性糖皮质激素过多通过上调Wnt信号拮抗剂和调控间充质干细胞定向的miR异常,抑制骨形成。
研究设计与样本
- 从16例临床和生化确诊的库欣病患者及10例按性别、年龄和体重指数匹配的临床无功能垂体腺瘤患者经蝶窦腺瘤切除术中获取蝶骨(蝶鞍)骨样本。
- 采用定量聚合酶链反应(qPCR)检测基于动物和细胞培养研究已知参与骨重塑调控的基因(mRNA和miR)表达。
主要发现
- 皮质醇增多与成骨细胞功能和成熟相关基因(ACP5、ALPL、BGLAP、COL1A1、COL1A2、BMP2、RUNX2、TWIST1)下调相关。
- 糖皮质激素过多导致Wnt信号拮抗剂(Dkk1、SOST)表达增加及抑制成骨细胞生成的miR(miR-125b-5p、miR-218-5p、miR-34a-5p、miR-188-3p、miR-199a-5p)水平改变,p<0.05,q<0.1。
- 长期皮质醇增多症中可见代偿机制:Wnt10b、LRP5和LRP6上调;SFRP4下调;参与成骨细胞生成的miR(miR-210-5p、miR-135a-5p、miR-211、miR-23a-3p、miR-204-5p)改变;破骨细胞生成相关基因下调。
- 上述改变均未能阻止骨形成受抑。
关键数值与推荐
- 皮质醇增多症中成骨细胞功能与成熟相关基因下调、Wnt信号拮抗剂(Dkk1、SOST)表达增加及抑制成骨细胞生成的miR水平改变,p<0.05,q<0.1。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Hypercortisolism in humans suppresses osteoblastogenesis and osteoblast function through the upregulation of Wnt-signaling antagonists (sclerostin, Dkk1) and changes in microRNAs levels (miR-125b-5p, miR-218-5p, miR-34a-5p, miR-188-3p, miR-199a-5p) which are associated with mesenchymal stem-cell commitment to adipocytes or cartilage cells over the osteoblasts. INTRODUCTION: The purpose of this study was to evaluate the responses of bone to chronic glucocorticoid (GC) excess by measuring the levels of selected mRNA and microRNA (miR) in bone samples of patients with Cushing's disease (CD). METHODS: Bone samples were obtained during transsphenoidal adenomectomy from the sphenoid bone (sella turcica) from 16 patients with clinically and biochemically evident CD and 10 patients with clinically non-functioning pituitary adenomas (NFPA) matched by sex, age, and body mass index. Quantitative polymerase chain reactions (qPCR) were used to examine the expression of genes (mRNA and miRs) known to be involved in bone remodeling regulation based on studies in animals and cell culture. RESULTS: Hypercortisolism was associated with the downregulation of genes involved in osteoblast function and maturation (ACP5, ALPL, BGLAP, COL1A1, COL1A2, BMP2, RUNX2, TWIST1). An excess of GC caused increased expression of Wnt-signaling antagonists (Dkk1, SOST) and changes in the levels of miRs that are known to suppress osteoblastogenesis (miR-125b-5p, miR-218-5p, miR-34a-5p, miR-188-3p, miR-199a-5p) p < 0.05, q < 0.1. Interestingly, compensatory mechanisms were found in long-term hypercortisolism: upregulation of Wnt10b, LRP5, and LRP6; downregulation of SFRP4; changes in miRs involved in osteoblastogenesis (miR-210-5p, miR-135a-5p, miR-211, miR-23a-3p, miR-204-5p); and downregulation of genes associated with osteoclastogenesis. None of these changes prevented the suppression of bone formation. CONCLUSIONS: An excess of endogenous GC in humans suppresses bone formation through the upregulation of Wnt-signaling antagonists and dysregulation of miRs involved in mesenchymal stem-cell commitment. Both Wnt-signaling antagonists and miRs seem to be promising targets for further research in therapeutic intervention in glucocorticoid-induced osteoporosis.
引用
- Belaya ZE, Grebennikova TA, Melnichenko GA, et al. Effects of endogenous hypercortisolism on bone mRNA and microRNA expression in humans. Osteoporos Int. 2017. PMID: 28980049. doi:10.1007/s00198-017-4241-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。